in

COVID-19 vaccines: science, safety, efficacy and distribution: large series, part one



The Department of Anesthesiology and Perioperative Medicine at Dartmouth-Hitchcock Health (D-HH) is pleased to host a two-part session focusing on the science, safety and efficacy of COVID mRNA vaccines and distribution plans and state allowance and D-HH. Kathryn Stephenson, MD, MPH, Director of the Clinical Trials Unit at the Harvard Center for Virology and Vaccine Research and Infectious Disease Specialist, discusses the biological basis of COVID vaccine development, as well as the clinical trial process. It also addresses concerns about the rigor of testing and the likelihood of sustained immunity in addition to potential complications. Laura Chiang, MD, moderates the series. Dr Chiang is Vice President of Education in the Department of Anesthesiology and Medical Co-Director of the Surgical Intensive Care Unit. Two of D-HH’s own infectious doctors join Dr. Chiang on the series. Elizabeth Talbot, MD, Deputy NH’s State Epidemiologist, and Michael Calderwood, MD, MPH, Deputy Director of Quality at D-HH, help answer questions from attendees of this session and will present Part 2 of the series on Monday December. 21, 2020. This session was recorded via Zoom on Friday, December 18, 2020.
#COVID19 #vaccines #science #safety #efficacy #distribution #large #series #part

Almond Foaming Shaving Cream gives me the smoothest shave I’ve found

Will American single malt ever compete with Scotch whiskey? Podcast Life Behind Bars